Altimmune:HC Wainwright & Co. raises PT to $25, maintains Buy rating.

lunes, 16 de marzo de 2026, 12:31 pm ET1 min de lectura
ALT--

Altimmune:HC Wainwright & Co. raises PT to $25, maintains Buy rating.

Altimmune:HC Wainwright & Co. raises PT to $25, maintains Buy rating.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios